Cambridge Investment Research Advisors
CHE icon

Cambridge Investment Research Advisors’s Chemed CHE Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
2,384
+229
+11% +$96.3K ﹤0.01% 2053
2026
Q1 		$814K Buy
2,155
+787
+58% +$337K ﹤0.01% 2353
2025
Q4 		$585K Sell
1,368
-28
-2% -$12.2K ﹤0.01% 2572
2025
Q3 		$625K Sell
1,396
-76
-5% -$34.4K ﹤0.01% 2458
2025
Q2 		$717K Buy
1,472
+60
+4% +$34.2K ﹤0.01% 2222
2025
Q1 		$869K Sell
1,412
-156
-10% -$88.7K ﹤0.01% 1973
2024
Q4 		$831K Sell
1,568
-12,427
-89% -$7.01M ﹤0.01% 2016
2024
Q3 		$8.41M Buy
13,995
+12,652
+942% +$7.17M 0.03% 566
2024
Q2 		$729K Buy
1,343
+1
+0.1% +$573 ﹤0.01% 2003
2024
Q1 		$861K Sell
1,342
-59
-4% -$35.8K ﹤0.01% 1831
2023
Q4 		$819K Sell
1,401
-16
-1% -$8.95K ﹤0.01% 1788
2023
Q3 		$736K Buy
1,417
+15
+1% +$7.8K ﹤0.01% 1774
2023
Q2 		$759K Buy
1,402
+73
+5% +$39.9K ﹤0.01% 1809
2023
Q1 		$715K Sell
1,329
-500
-27% -$255K ﹤0.01% 1809
2022
Q4 		$934K Sell
1,829
-16
-0.9% -$7.79K ﹤0.01% 1558
2022
Q3 		$805K Sell
1,845
-25
-1% -$12K ﹤0.01% 1623
2022
Q2 		$878K Buy
1,870
+12
+0.6% +$5.85K ﹤0.01% 1569
2022
Q1 		$941K Sell
1,858
-52
-3% -$24.9K ﹤0.01% 1613
2021
Q4 		$1.01M Sell
1,910
-2
-0.1% -$960 ﹤0.01% 1580
2021
Q3 		$889K Hold
1,912
– – ﹤0.01% 1632
2021
Q2 		$907K Buy
1,912
+8
+0.4% +$3.84K ﹤0.01% 1598
2021
Q1 		$876K Buy
1,904
+43
+2% +$21.1K ﹤0.01% 1520
2020
Q4 		$991K Sell
1,861
-431
-19% -$212K 0.01% 1305
2020
Q3 		$1.1M Sell
2,292
-137
-6% -$67.2K 0.01% 1131
2020
Q2 		$1.1M Buy
2,429
+246
+11% +$110K 0.01% 1078
2020
Q1 		$946K Buy
2,183
+764
+54% +$341K 0.01% 1003
2019
Q4 		$623K Sell
1,419
-45
-3% -$18.9K ﹤0.01% 1438
2019
Q3 		$611K Buy
1,464
+29
+2% +$11.8K 0.01% 1368
2019
Q2 		$518K Buy
1,435
+14
+1% +$4.68K ﹤0.01% 1396
2019
Q1 		$455K Buy
1,421
+12
+0.9% +$3.69K ﹤0.01% 1547
2018
Q4 		$399K Buy
1,409
+185
+15% +$55.8K ﹤0.01% 1448
2018
Q3 		$391K Sell
1,224
-41
-3% -$13.1K ﹤0.01% 1607
2018
Q2 		$407K Sell
1,265
-12
-0.9% -$3.75K ﹤0.01% 1524
2018
Q1 		$349K Buy
1,277
+6
+0.5% +$1.59K ﹤0.01% 1562
2017
Q4 		$309K Buy
1,271
+7
+0.6% +$1.59K ﹤0.01% 1634
2017
Q3 		$255K Sell
1,264
-2,691
-68% -$529K ﹤0.01% 1666
2017
Q2 		$809K Buy
3,955
+769
+24% +$153K 0.01% 917
2017
Q1 		$582K Buy
3,186
+1,548
+95% +$270K 0.01% 994
2016
Q4 		$263K Buy
1,638
+155
+10% +$22.8K ﹤0.01% 1351
2016
Q3 		$209K Buy
+1,483
New +$206K ﹤0.01% 1522

Other funds holding CHE

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
FAM
Fenimore Asset Management Cobleskill, New York $4.83B AUM 9.09% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
SRS
Strong Retirement Solutions Silverdale, Washington $167M AUM

Cambridge Investment Research Advisors's CHE Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Chemed (CHE) stake by 11% in Q2 2026, buying an estimated $96.3K and bringing the position to 2,384 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Cambridge Investment Research Advisors first reported a position in CHE in Q3 2016 and has held it in 40 quarters since. The position peaked at $8.41M in Q3 2024. 125 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Cambridge Investment Research Advisors held 2,384 shares of Chemed worth $1.11M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 229 Chemed shares in Q2 2026, an estimated $96.3K.
  • Chemed made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2053 holding.
  • Cambridge Investment Research Advisors first reported a position in Chemed in Q3 2016 and has held it in 40 quarters since.
  • Cambridge Investment Research Advisors's Chemed position peaked at $8.41M in Q3 2024.
  • 125 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.